Jim Simons
LABU icon

Jim Simons’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Jim Simons’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,900
Closed -$3.65M – 3495
2025
Q4 		$3.65M Buy
22,900
+2,200
+11% +$302K 0.01% 1511
2025
Q3 		$1.94M Sell
20,700
-5,200
-20% -$367K ﹤0.01% 2097
2025
Q2 		$1.47M Buy
+25,900
New +$1.37M ﹤0.01% 2298
2024
Q1 		– Sell
-4,400
Closed -$537K – 3908
2023
Q4 		$537K Buy
+4,400
New +$337K ﹤0.01% 2742
2022
Q2 		– Sell
-9,100
Closed -$2.85M – 4421
2022
Q1 		$2.85M Buy
+9,100
New +$3.43M ﹤0.01% 1961

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Jim Simons's LABU Position: Q1 2026 in Review

Jim Simons sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 22,900 shares — an estimated $3.65M sold.

Jim Simons first reported a position in LABU in Q1 2022 and held it in 5 quarters. The position peaked at $3.65M in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Jim Simons reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 22,900 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $3.65M.
  • Jim Simons first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2022 and held it in 5 quarters.
  • Jim Simons's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.65M in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.